Robert W Simms MD Professor of Medicine
Rheumatoid Arthritis & Related, Scleroderma & Related
Professor of Medicine, Boston University
Join to View Full Profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-650-8622
Fax+1 603-650-4691
Dr. Simms is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterFellowship, Rheumatology, 1985 - 1987
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1980 - 1981
University of Rochester School of Medicine and DentistryClass of 1980
Certifications & Licensure
NY State Medical License 1982 - Present
NH State Medical License 2020 - 2026
VT State Medical License 2022 - 2026
MA State Medical License 1982 - 2023
ME State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Boston Magazine Castle Connolly, 2008-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
Publications & Presentations
PubMed
- 3 citationsGeographic Clustering of Systemic Sclerosis in Areas of Environmental Pollution.Noelle N Kosarek, Megan E Romano, Erika L Moen, Robert W Simms, Ashleigh Erickson
Arthritis Care & Research. 2025-07-01 - 3 citationsAutologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Te...George E Georges, Dinesh Khanna, Mark H Wener, Matthew G Mei, Maureen D Mayes
Arthritis & Rheumatology. 2025-05-01 - 23 citationsEfficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.Robert Spiera, Masataka Kuwana, Dinesh Khanna, Laura Hummers, Tracy M Frech
Arthritis & Rheumatology. 2023-09-01
Journal Articles
- Serum Biomarker for Diagnostic Evaluation of Pulmonary Arterial Hypertension in Systemic SclerosisHarrison W Farber, Kari Roberts, Nicholas Hill, Robyn Domsic, Robert W Simms, BioMed Central
Grant Support
- Core B Clinical CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- High-Dose Immunosuppressive Therapy Using Total Body IrradiationNational Center For Research Resources2007
- Infusion Of Recombinant Human Relaxin In Patients W/ SclerodermaNational Center For Research Resources1999–2000
- Muscle Metabolism And Muscle Fatigue In Fibromyalgia SyndromeNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
